GtoPdb Ligand ID: 6770

Synonyms: campath 1H | Campath® | campath-1H | Lemtrada®
alemtuzumab is an approved drug (FDA (2001), EMA (2013))
Compound class: Antibody
Comment: CAMPATH-1 (CD52) antigen inhibitor. Functionally, alemtuzumab causes depletion and then recovery of the immune system.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: alemtuzumab

Compound class Antibody
Approved drug? Yes (FDA (2001), EMA (2013))
International Nonproprietary Names
INN number INN
8005 alemtuzumab
campath 1H | Campath® | campath-1H | Lemtrada®
Database Links
Specialist databases
IMGT/mAb-DB 11
Other databases
GtoPdb PubChem SID 178103376
PubChem SID 178103376
Search PubMed clinical trials alemtuzumab
Search PubMed titles alemtuzumab
Search PubMed titles/abstracts alemtuzumab
Wikipedia Alemtuzumab